Rockefeller Capital Management
CRNX icon

Rockefeller Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Rockefeller Capital Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$173K Buy
2023
Q1 		– Sell
2022
Q4 		$18K Hold
2022
Q3 		$19K Buy
2020
Q1 		– Sell
2019
Q4 		$177K Buy
2019
Q3 		$45K Sell
2019
Q2 		$79K Hold
2019
Q1 		$72K Hold
2018
Q4 		$95K Hold
2018
Q3 		$91K Buy